Výsledky vyhledávání - "Alvaro Borela"

Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations—When Is the Best Time to Measure?

Autor: E.M.F.L. Domingues, M.I. de Holanda, A.M.G. Santos, T Matuck, D.S. Glasberg, Daniel D. De Carvalho, R. Curvo, Alvaro Borela, Luís Cristóvão Porto

Publikováno v: Transplantation Proceedings. 50:728-736

Background Pretransplantation soluble CD30 (sCD30) has been shown to be a good predictor of acute rejection (AR) and graft loss. This study aimed to evaluate the effectiveness of sCD30 measured pretransplant and up to 6 months after transplantation a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5db99bfa8ded004f203461dcccfb9461
https://doi.org/10.1016/j.transproceed.2018.02.025

Zobrazit plný text záznamu

EXPERIÊNCIA COM USO DE BASILIXIMAB (SIMULECT®) EM UM ÚNICO SERVIÇO DE TRANSPLANTE RENAL

Autor: Jayne Almeida da Trindade, Deise Monteiro de Carvalho, Marília Drumond Reis, Ana Cláudia Pires, Alvaro Borela, Maria de Fátima Alvarenga, Luciano Morgado, Miguel Luis Graciano, T Matuck

Publikováno v: Brazilian Journal of Transplantation. 8:255-258

Objetivos: Avaliar a eficácia e a segurança do uso de Basiliximab, anticorpo monoclonal quimérico que atua bloqueando o receptor de interleucina-2, na profilaxia de rejeição aguda em transplantes renais de alto risco realizados entre agosto/1999

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::dba08cae6ec61677943bb8d7edb10960
https://doi.org/10.53855/bjt.v8i1.412

Zobrazit plný text záznamu